Search hospitals
>
Nebraska
>
Omaha
Creighton University Medical Center
Claim this profile
Omaha, Nebraska 68131
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
Conducts research for Pancreatic Cancer
368 reported clinical trials
3 medical researchers
Summary
Creighton University Medical Center is a medical facility located in Omaha, Nebraska. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Creighton University Medical Center is involved with conducting 368 clinical trials across 497 conditions. There are 3 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, and Mehmet S. Copur.
Area of expertise
Breast Cancer
Creighton University Medical Center has run 71 trials for Breast Cancer. Some of their research focus areas include:
Lung Cancer
Creighton University Medical Center has run 56 trials for Lung Cancer. Some of their research focus areas include:
Top PIs
Richard L. Deming
Mercy Medical Center - Des Moines
7 years of reported clinical research
Shahzad Siddique
Penrose-Saint Francis Healthcare
3 years of reported clinical research
Mehmet S. Copur
Bethesda North Hospital
13 years of reported clinical research
Clinical Trials running at Creighton University Medical Center
Bladder Cancer
Lung Cancer
Prostate Cancer
Breast Cancer
Breast cancer
Esophageal cancer
Ovarian Cancer
Multiple Myeloma
Bladder Carcinoma
Colorectal Cancer
Gemcitabine + Docetaxel vs BCG
for Bladder Cancer
This trial is testing whether a combination of two drugs, Gemcitabine and Docetaxel, given directly into the bladder, is effective for patients with high-grade non-muscle invasive bladder cancer who have not been treated with the standard therapy before. The goal is to see if this new treatment can prevent cancer from coming back or spreading. The study will also look at the quality of life, safety, and side effects of the new treatment. Gemcitabine and Docetaxel have shown promise as an alternative treatment, especially in cases where the standard therapy fails or is not tolerated.
Recruiting
2 awards
Phase 3
14 criteria
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting
2 awards
Phase 3
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting
1 award
Phase 2
21 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Creighton University Medical Center?
Creighton University Medical Center is a medical facility located in Omaha, Nebraska. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Cancer, Pancreatic Cancer and other specialties. Creighton University Medical Center is involved with conducting 368 clinical trials across 497 conditions. There are 3 research doctors associated with this hospital, such as Richard L. Deming, Shahzad Siddique, and Mehmet S. Copur.
Where is Creighton University Medical Center located?
To reach Creighton University Medical Center in Omaha, NE, take I-680 to exit 4 for Mercy Road, then head north for about a mile to the hospital located at 7500 Mercy Rd.
Who should I call to ask about financial aid or insurance network?
**Creighton University Medical Center Financial Assistance:** - **Contact Information:** For financial assistance, reach out to the Financial Aid Office via email at finaid@creighton.edu or call 800.282.5835 / 402.280.2731. They assist with undergraduate, graduate, or professional school financial inquiries. For specific staff contacts, visit the Creighton University website. **Insurance-Related Inquiries:** - **Contact Information:** For insurance questions, waivers, or enrollment in the University-sponsored Student Health Insurance Plan, contact the Student Health Education and Compliance Office at studentinsurance@creighton.edu or call 402.280.2735.
What insurance does Creighton University Medical Center accept?
The Creighton University Medical Center accepts UnitedHealthcare Student Resources and UnitedHealthcare medical coverage. Students can benefit from the university-sponsored Student Health Insurance Plan, offering comprehensive medical and mental health care. Employees have three plan options: Creighton Consumer Account Plan (CCAP), PPO1, and PPO2, with pharmacy benefits by Express Scripts, dental by MetLife, and vision by Vision Service Plan (VSP).
What awards or recognition has Creighton University Medical Center received?
Creighton University Medical Center, located in Omaha, Nebraska, is celebrated for its high-quality care, as recognized by U.S. News. The university's Division of Clinical Research enhances clinical studies by assisting in various stages including IRB submission and study management. Its research excellence spans cancer, antibiotic development, diabetes, and hearing, with significant accomplishments in hereditary and skin cancer, breast and prostate cancer, and hearing loss prevention.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.